EU holds up ChemChina's $43 billion acquisition of Syngenta
- Wall Street ends down as Trump focuses on trade
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- Qualcomm (QCOM) Thrashed as Apple (AAPL) Lawsuit Threatens Licensing Business Model
- McDonald's (MCD) Tops Q4 EPS by 3c
A woman checks her phone at the headquarters of China National Chemical Corporation in Beijing, July 20, 2009. REUTERS/Stringer/File Photo
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
By Julia Fioretti
BRUSSELS (Reuters) - European Union antitrust regulators on Friday opened an in-depth investigation into state-owned Chinese chemicals group ChemChina's $43 billion bid for Swiss pesticides and seeds group Syngenta
Syngenta's shares plunged over 9 percent on Monday after the European Commission said the companies had not allayed its concerns over the deal, raising the prospect of a longer investigation.
The Commission said the merger could harm competition as Syngenta and ChemChina, through its agrichemical subsidiary Adama Agricultural Solutions (NASDAQ: ADAM), had overlapping portfolios in the production of crop protection products like herbicides, insecticides, fungicides and plant growth regulators.
"This deal would lead to the combination of a leading crop protection company with one of its main generic competitors. Therefore we need to carefully assess whether the proposed merger would lead to higher prices or a reduced choice for farmers," said Margrethe Vestager, EU Competition Commissioner.
The Commission will decide by March 15 whether to approve the deal.
Clinching the deal is taking longer than planned amid a flurry of deals in the agriculture sector that Syngenta, the world's biggest pesticides maker, said had swamped competition watchdogs.
ChemChina submitted a proposal to the Commission in September, including a plan to divest some $20 million worth of assets from Adama Agricultural Solutions, a Beijing-based source told Reuters.
The company is ready to offer more concessions to win EU approval, the source said.
(Reporting by Julia Fioretti; Editing by Greg Mahlich)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silgan (SLGN) to Acquire WestRock's (WRK) Specialty Closures and Dispensing Systems Business for $1.03B
- ADMA Biologics (ADMA) to Acquire Assets from Biotest Pharmaceuticals
- Avis Budget Group (CAR) Adopts Short-Term Stockholder Rights Plan
Create E-mail Alert Related CategoriesReuters
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!